### ğŸ« Pulmonology: Asthma Management During Pregnancy

#### âœ… True Statements
1. Treatment of **asthma during pregnancy** is similar to treatment in **nonpregnant patients**.
2. **Inhaled glucocorticoids** are considered **safe in pregnancy**.
3. **Budesonide** has abundant long-term safety data and is the **preferred inhaled glucocorticoid** in pregnancy.
4. With the exception of **zileuton**, most **leukotriene modifiers** are considered **safe in pregnancy**.
5. **Low-dose inhaled glucocorticoid plus a short-acting Î²2-agonist (SABA)** is the recommended therapy for **mild persistent asthma** during pregnancy.
6. Untreated **maternal asthma** increases the risk of **perinatal mortality**, **preterm birth**, **low birth weight**, and **preeclampsia**.
7. Treatment with a **regular daily low-dose inhaled glucocorticoid** and an **as-needed SABA** reduces **asthma symptoms**, **severe exacerbations**, **hospitalization**, and **death**.
8. For **persistent asthma symptoms or exacerbations** despite low-dose inhaled glucocorticoid and as-needed SABA, the preferred **step-up therapy** is a **combination of low-dose inhaled glucocorticoid and long-acting Î²2-agonist (LABA)**, such as **fluticasone-salmeterol** or **budesonide-formoterol**.
9. **Prednisone** is used to treat **asthma exacerbations** but is **not indicated** for mild persistent asthma without evidence of exacerbation.
10. All patients with asthma should have a **written asthma action plan** for management of exacerbations and initiation of **self-treatment**.
11. **Peak flow monitoring alone** is not appropriate without initiation of **pharmacotherapy** in patients with frequent asthma symptoms.

#### ğŸ’¬ Extra
5. Symptoms more than twice weekly define **mild persistent asthma**, warranting daily controller therapy.
6. The **risks of untreated asthma** outweigh potential risks of **asthma medications** in pregnancy.

#### ğŸ·ï¸ Tags
#Pulmonology #Asthma #Pregnancy #Budesonide #Glucocorticoids #SABA #LABA #MaternalHealth #AmbulatoryCare

#### ğŸ“š Reference
Huang J, Namazy J. Asthma in pregnancy. *JAMA*. 2023;329:1981-1982. PMID: 37234011 doi:10.1001/jama.2023.5588

#### ğŸ†” Question ID
PMQQQ24008

#### ğŸ•’ Last Updated
February 2025

---

#### ğŸ“– Related Text
MKSAP 19: Pulmonary Medicine â€” Airways Disease, Asthma, Asthma in Pregnancy

---

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements â€” Asthma in Pregnancy
1. Pregnancy can lead to **worsened or improved asthma control**.
2. **Asthma exacerbations** occur most frequently during the **second trimester of pregnancy**.
3. Pregnant patients should be advised that the **advantages of asthma treatment outweigh the potential fetal risks**.
4. **Inhaled glucocorticoids, oral glucocorticoids, short-acting Î²2-agonists (SABAs), leukotriene receptor antagonists (montelukast, zafirlukast), and long-acting Î²2-agonists (LABAs)** have all been used extensively in pregnancy without data suggesting **fetal harm**.

#### ğŸ’¬ Extra
3. Counseling pregnant patients improves **treatment adherence** by emphasizing maternal and fetal benefits.

#### ğŸ·ï¸ Tags
#Asthma #Pregnancy #Exacerbation #Glucocorticoids #SABA #LABA #LeukotrieneAntagonists
